Cargando…
Established Liposome-Coated IMB16-4 Polymeric Nanoparticles (LNPs) for Increasing Cellular Uptake and Anti-Fibrotic Effects In Vitro
As a global health problem, liver fibrosis still does not have approved treatment. It was proved that N-(3,4,5-trichlorophenyl)-2(3-nitrobenzenesulfonamide) benzamide (IMB16-4) has anti-hepatic fibrosis activity. However, IMB16-4 displays poor water solubility and poor bioavailability. We are devote...
Autores principales: | Niu, Xia, Meng, Yanan, Wang, Yucheng, Li, Guiling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230879/ https://www.ncbi.nlm.nih.gov/pubmed/35744862 http://dx.doi.org/10.3390/molecules27123738 |
Ejemplares similares
-
New IMB16-4 Nanoparticles Improved Oral Bioavailability and Enhanced Anti-Hepatic Fibrosis on Rats
por: Niu, Xia, et al.
Publicado: (2022) -
Novel IMB16-4 Compound Loaded into Silica Nanoparticles Exhibits Enhanced Oral Bioavailability and Increased Anti-Liver Fibrosis In Vitro
por: Niu, Xia, et al.
Publicado: (2021) -
Costunolide Loaded in pH-Responsive Mesoporous Silica Nanoparticles for Increased Stability and an Enhanced Anti-Fibrotic Effect
por: Niu, Xia, et al.
Publicado: (2021) -
siRNA Functionalized Lipid Nanoparticles (LNPs) in Management of Diseases
por: Kalita, Tutu, et al.
Publicado: (2022) -
Neutrino measurements with the IMB detector
por: Becker-Szendy, R A, et al.
Publicado: (1994)